47 results
8-K
EX-99.1
PYXS
Pyxis Oncology Inc
10 Jun 24
Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger
7:56am
building companies that drive innovation will be invaluable.”
“Pyxis Oncology’s novel ADC approach and impressive pipeline comprised of next-generation
8-K
EX-99.1
PYXS
Pyxis Oncology Inc
14 May 24
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
7:55am
talent to drive its mission of transforming cancer care through innovation.
Program and Corporate Updates
PYX-201 in the PYX-201-101 trial: To date
8-K/A
EX-99.2
yf37e4bgdqh
27 Oct 23
Index to Consolidated Financial Statements
4:34pm
8-K
EX-99.1
l20uma78yd 9zydnyj8
23 Aug 23
Pyxis Oncology Successfully Completes Acquisition of Apexigen
8:47am
425
arsdabrryzr
11 Aug 23
Business combination disclosure
7:26am
8-K
EX-99.1
vr2n5xdbl7
11 Aug 23
Pyxis Oncology Reports Financial Results for Second-Quarter 2023
7:25am
424B3
pbshpga
30 Jun 23
Prospectus supplement
4:05pm
S-4/A
kgs2v1
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4
24wn7
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
425
tlwk 0forjhue1hw
25 May 23
Business combination disclosure
8:14am
425
czx2kj0qx7 zarg4byle
24 May 23
Business combination disclosure
5:00pm
425
ypez2l0yd
24 May 23
Business combination disclosure
7:05am
425
lamt d9q1dyaf
24 May 23
Business combination disclosure
7:03am
8-K
EX-99.1
80c 9qq9uu
24 May 23
Pyxis Oncology to Acquire Apexigen
6:59am